Does Ginkgo Biloba Work? What the Science Says
Ginkgo biloba evidence spans over four decades of research, making it one of the most studied herbal supplements in Western science. The extract — standardised to contain 24% flavone glycosides and 6% terpene lactones (EGb 761 is the most-studied formulation) — is commonly used for cognitive support and circulation.
This article examines the mechanism, what controlled trials actually show, who tends to benefit, and what EFSA has and has not approved.
What It Is and How It Works
Ginkgo biloba leaf extract contains flavonoids (quercetin, kaempferol, isorhamnetin) and terpenoids (ginkgolides, bilobalide). The proposed mechanisms include inhibition of platelet-activating factor, antioxidant activity, and improved microvascular blood flow — all of which could, in theory, support cerebral circulation and reduce oxidative stress in neural tissue.
These mechanisms are plausible and well-characterised in in-vitro and animal models. The question is how robustly they translate to clinically meaningful effects in healthy and cognitively declining humans.
What the RCT and Meta-Analysis Evidence Shows
The most comprehensive assessment of Ginkgo biloba for cognitive outcomes in older adults with mild cognitive impairment was a large multi-centre RCT (GuidAge study) that found no significant difference in progression to Alzheimer's disease compared to placebo over five years (Vellas et al., 2012).
A Cochrane systematic review of Ginkgo biloba for dementia and cognitive impairment (Birks & Grimley Evans, 2009) concluded that the evidence is inconsistent and unreliable, with small positive effects in some older trials that have not been replicated in larger, better-controlled studies.
For healthy adults without cognitive decline, a systematic review by Canter & Ernst (2007) found no convincing evidence that Ginkgo biloba improves memory or cognitive function. The positive effects observed in small studies did not hold up in larger ones.
Effect Sizes and Who Benefits
The most credible positive evidence relates to peripheral arterial disease and intermittent claudication (leg pain on walking due to poor circulation), where a Cochrane review found modest improvements in pain-free walking distance (Nicolaï et al., 2013). This represents a legitimate, if modest, circulatory benefit.
For cognitive outcomes, effect sizes in the studies that did show positive results were small. The subset of older adults with subjective memory complaints and early-stage cognitive changes may see some benefit — but healthy young individuals show no reliable cognitive enhancement from Ginkgo biloba.
You can find Ginkgo biloba products available at maxfit.ee in the Ginkgo biloba category.
EFSA-Approved Claims Only
EFSA has not authorised any health claims for Ginkgo biloba leaf extract in the EU. This means no legally compliant product label can claim that Ginkgo biloba improves memory, supports cognitive function, or benefits circulation in approved language.
The traditional use authorisation under EU herbal medicine regulation (HMPC) permits the descriptor "traditionally used to relieve symptoms of cognitive impairment related to ageing" only under conditions that make clear this is traditional use, not clinically proven efficacy.
Honest Verdict
Ginkgo biloba is one of the more honestly tested botanical supplements — the research has been extensive and the negative findings from large trials have been published without suppression. The evidence for cognitive enhancement in healthy people or as a dementia preventive is not convincing. The evidence for peripheral circulation improvement is modest but more consistent.
If you are considering Ginkgo biloba as part of a broader lifestyle approach to brain health, the risk profile at standard doses is generally acceptable, but manage expectations based on the actual evidence rather than marketing claims.
FAQ
Does Ginkgo biloba improve memory in healthy adults?
Large, well-controlled studies have not found reliable memory improvement in healthy adults without cognitive decline. Smaller positive studies have not been consistently replicated.
How long do you need to take Ginkgo biloba to see effects?
Trials reporting any positive effects typically ran for 12–24 weeks. Short-term (under 4 weeks) use is unlikely to produce the effects described in the literature.
Is Ginkgo biloba safe to take with medications?
Ginkgo biloba has antiplatelet properties and can interact with blood-thinning medications (warfarin, aspirin, NSAIDs). If you take any of these, consult a healthcare professional before starting Ginkgo biloba.
References
Vellas, B., Coley, N., Ousset, P. J., Berrut, G., Dartigues, J. F., Dubois, B., et al. (2012). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet Neurology, 11(10), 851–859. PMID: 22959217 https://pubmed.ncbi.nlm.nih.gov/22959217/
Birks, J., & Grimley Evans, J. (2009). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, (1), CD003120. PMID: 19160216
Canter, P. H., & Ernst, E. (2007). Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people. Human Psychopharmacology, 22(5), 265–278. PMID: 17457961 https://pubmed.ncbi.nlm.nih.gov/17480002/
Nicolaï, S. P., Kruidenier, L. M., Bendermacher, B. L., Prins, M. H., Stokmans, R. A., Broos, P. P., et al. (2013). Ginkgo biloba for intermittent claudication. Cochrane Database of Systematic Reviews, (6), CD006888. PMID: 23744597
